Concepedia

Mona Alibolandi

MA

Statistics

Publications

102

Citations

5.2K

H-Index

42

Active since

2013

Affiliations

Mashhad University of Medical Sciences(Current)

Biotechnology Research Center

Ferdowsi University of Mashhad

Academic Center for Education, Culture and Research

Mona Alibolandi is an author at Mashhad University of Medical Sciences specializing in drug delivery, pharmaceutics, and pharmacy.

ORCID

Publications per year

2013–2025

102

Publications

102

Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer

Elnaz Bagheri, Khalil Abnous, Sara Amel Farzad et al. · Life Sciences · 2020 · 244 citations

, , +16

Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation

Mona Alibolandi, Khalil Abnous, Fatemeh Sadeghi et al. · International Journal of Pharmaceutics · 2016 · 168 citations

, , +16

Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo

Mona Alibolandi, Seyed Mohammad Taghdisi, Pouria Ramezani et al. · International Journal of Pharmaceutics · 2017 · 158 citations

, , +16

Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score

Fazileh Hosseini Shamili, Mona Alibolandi, Houshang Rafatpanah et al. · Journal of Controlled Release · 2019 · 152 citations

, , +16

In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer

Mona Alibolandi, Mohammad Ramezani, Khalil Abnous et al. · Journal of Controlled Release · 2015 · 146 citations

, , +16

1–5 of 102